FY2025 · ended Dec 31, 2025 · Revenue $44.05M, +35.0% YoY · Filed Mar 26, 2026
SANUWAVE Health, Inc. (SNWV) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $44.1 million and net income of $11.8 million. Free cash flow was $1.9 million. As of Jun 30, 2026 it held $9.4 million in cash and investments and $1.5 million in total debt.
Revenue (TTM)
$44.02M
+12.1% vs year-ago TTM
Net income (TTM)
$15.26M
+138.1% vs year-ago TTM
Operating cash flow (TTM)
$5.22M
+248.4% vs year-ago TTM
Free cash flow (TTM)
$4.24M
+4103.8% vs year-ago TTM
EPS (TTM)
$1.68
+128.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
8.59M
+0.5% vs prior year
Net cash
$7.85M
as of Jun 30, 2026
Operating margin
3.4%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SNWV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Eden Prairie, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1417663
- Former names
- RUB MUSIC ENTERPRISES, INC. (until Feb 1, 2010)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $44.1M | $32.6M | $19.3M | $15.5M | $11.4M |
| Operating income | $4.9M | $3.8M | -$540,000 | -$9.0M | -$14.1M |
| Net income | $11.8M | -$33.1M | -$25.8M | -$10.3M | -$27.3M |
| Diluted EPS | $0.41 | -$7.41 | -$12.19 | -$0.02 | -$0.05 |
| Operating cash flow | $3.9M | $2.5M | -$4.5M | -$17.2M | -$6.4M |
| Free cash flow | $1.9M | $2.0M | — | — | -$6.9M |
| Total assets | $37.3M | $30.1M | $22.4M | $19.9M | $18.6M |
| Total liabilities | $35.7M | $45.9M | $65.6M | $60.9M | $57.6M |
| Stockholders' equity | $1.6M | -$15.8M | -$44.5M | -$41.0M | -$39.0M |
| Cash and investments | $12.0M | $10.2M | $1.8M | $1.2M | $619,000 |
| Total debt | $22.9M | — | — | — | $26.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 25, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 13, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2026 | Jun 16, 2026 |
All 751 SANUWAVE Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.